ZertifikateAwards 2021/2022: Bitte stimmen Sie für finanzen.net zero und finanzen.net ab und gewinnen Sie eine Reise nach Berlin! -w-
21.09.2021 17:35

Philip Morris (PM) Strives to Expand IQOS & Beyond Nicotine

Folgen
Werbung
Renowned tobacco company, Philip Morris International Inc. PM, has been gaining from its efforts to expand in the reduced-risk products (“RRPs”) space as consumers become more conscious regarding health and wellness. The company’s much acclaimed IQOS — a heat-not-burn device — is among the leading RRPs in the industry.  It has also been making radical progress in the respiratory drug delivery platform, as part of the ‘Beyond Nicotine’ strategy announced earlier this year. Pricing power has played a key role in boosting the company’s top line.Shares of this Zacks Rank #3 (Hold) company have gained 12.2% in the past three months compared with the industry’s rise of 2.1%. That said, let’s discuss some of the key efforts and growth strategies undertaken by the company.Low-Risk & Beyond Nicotine Products Expansion on TrackRRPs, considered to be the next-generation tobacco products, have been gaining popularity owing to their less detrimental impacts on health. Consumers are inclining toward RRPs to quit or reduce cigarette consumption. Philip Morris is known for pioneering the shift from traditional cigarette to other low-risk alternatives. It had launched IQOS in the United States in 2019, through a commercial deal with Altria Group, Inc. MO that was approved by the FDA. Since then, the company has been expanding the brand by introducing its newer versions with improved features. Total users of IQOS as of the end of second-quarter 2021 were estimated to be about 20.1 million, including nearly 14.7 million users who have shifted from smoking to IQOS. Strong growth in IQOS boosted revenues in the RRPs category, which increased 41.7% to $2,276 million in the second quarter. Heated tobacco unit shipment volumes of 24.4 billion units rose 30.2% year over year.As part of its transformation efforts, the company is committed toward expanding IQOS. It has started commercializing IQOS VEEV, which is its new e-vapor product, and is also on track with the expansion of IQOS ILUMA. Such efforts keep the company well placed for its transition to a majority smoke-free company by 2025. The company is on track to achieve its 2021 goal of 95-100 billion shipments of heated tobacco units.Philip Morris has been firm on its ambitious plans to expand Beyond Nicotine products. As part of this initiative, the company has been striving to achieve world-class expertise, scientific know-how and capabilities to develop products focused on inhaled therapeutics and respiratory drug delivery platforms for medical as well as wellness applications. In February 2021, the company announced plans of generating at least $1 billion in annual net revenues from the Beyond Nicotine business by 2025.As part of the Beyond Nicotine strategy, the company acquired Fertin Pharma A/S — a leading manufacturer and developer of innovative pharmaceutical and well-being products that are based on oral and intra-oral delivery systems. Philip Morris acquired OtiTopic, a respiratory drug development company based in the United States. OtiTopic develops late-stage inhalable acetylsalicylic acid (“ASA”) treatment for acute myocardial infarction or heart attack. The company also secured more than 74% shares in Vectura Group plc, a provider of innovative inhaled drug delivery solutions for treating diseases related to smoking.Image Source: Zacks Investment ResearchStrong Pricing Supports RevenuesStrong pricing for tobacco products has been a significant upside for Philip Morris. This has been boosting the company’s revenues and adjusted operating income. Though higher pricing might lead to possible decline in cigarette consumption, it is seen that smokers tend to absorb price increases due to the addictive quality of cigarettes. Higher pricing variance was an upside to the company’s performance during the second quarter. In fact, gains from pricing contributed to growth across most regions during the quarter. Pricing power is likely to keep aiding the company’s performance in the forthcoming periods.Wrapping UpPhilip Morris is undertaking every effort to transform itself into a company that puts health and wellbeing in the forefront. Its efforts to expand IQOS to support consumers’ shift from cigarettes to reduced risk options as well as moves undertaken as part of the Beyond Nicotine strategy are praiseworthy. Such prudent growth endeavors as well as gains from pricing are likely to keep supporting the company, as it battles headwinds related to the cigarette unit including stringent regulatory norms and declining market share.Tobacco Stocks You Can’t MissVector Group Ltd. VGR, flaunting a Zacks Rank #1 (Strong Buy), delivered an earnings surprise of 73% in the last four quarters, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.Turning Point Brands, Inc. TPB, with a Zacks Rank #2 (Buy), delivered an earnings surprise of 20.4% in the last four quarters, on average. 5 Stocks Set to Double Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Altria Group, Inc. (MO): Free Stock Analysis Report Philip Morris International Inc. (PM): Free Stock Analysis Report Vector Group Ltd. (VGR): Free Stock Analysis Report Turning Point Brands, Inc. (TPB): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Weiter zum vollständigen Artikel bei "Zacks"
Quelle: Zacks

Nachrichten zu Philip Morris Inc.

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Philip Morris Inc.

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
28.08.2019Philip Morris NeutralJP Morgan Chase & Co.
28.08.2019Philip Morris UnderperformCredit Suisse Group
19.07.2019Philip Morris OverweightBarclays Capital
23.05.2019Philip Morris Equal WeightBarclays Capital
20.07.2018Philip Morris BuyStifel, Nicolaus & Co., Inc.
19.07.2019Philip Morris OverweightBarclays Capital
20.07.2018Philip Morris BuyStifel, Nicolaus & Co., Inc.
10.04.2018Philip Morris BuyDeutsche Bank AG
16.10.2015Philip Morris International OverweightBarclays Capital
21.03.2013Philip Morris International kaufenJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
28.08.2019Philip Morris NeutralJP Morgan Chase & Co.
23.05.2019Philip Morris Equal WeightBarclays Capital
20.07.2018Philip Morris Market PerformCowen and Company, LLC
13.04.2015Philip Morris International HoldArgus Research Company
22.10.2012Philip Morris International holdJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Philip Morris Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Werbung
Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

Dow letztlich fester -- DAX schließt im Plus -- Software AG senkt Ausblick für Digital -- Delivery Hero steigt bei Gorillas ein -- GameStop, J&J, Apple, Munich Re, TeamViewer im Fokus

Amazon springt auf 3D-Audio-Zug auf. RWE will in Großbritannien bis 2030 rund 15 Milliarden Pfund investieren. E.ON nimmt Neukundengeschäft mit Gas wieder auf. Procter & Gamble veranlasst wegen steigender Kosten höhere Preise. Travelers übertrifft Erwartungen im dritten Quartal. Roche-Partner Atea kann mit Corona-Pille Ziele nicht erreichen. JENOPTIK übernimmt Berliner Glas Medical und Swissoptic.

Umfrage

Wo steht der DAX zum Jahresende?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln